MedTrace Logo

Probiotic Research: Open-label Functional Intervention and Longitudinal Evaluation in Healthy Adults

NCT07457242 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-03-09

No results posted yet for this study

Summary

This study is a pre-post, open-label cohort study designed to investigate how a food-grade probiotic supplement affects biological measurements and wellbeing in healthy adults. Participants will take one capsule daily for either 1 month or 6 months.

During the study, participants will complete online cognitive tasks and provide blood and stool samples collected during home visits by trained staff. The samples will be analysed to explore changes in gut bacteria and other biological markers.

This study aims to understand whether the supplement is well tolerated and whether measurable biological changes occur. The study does not involve any experimental drugs or invasive procedures beyond blood sampling and stool collection, and participants will not be asked to change any current prescribed medications or treatments; with eligibility exclusions applying for recent antibiotics or immunosuppressants. The supplement is being studied for research purposes only and is not intended to diagnose, treat, or prevent disease. Participants will be invited to participate in a follow-up visit to assess long-term effects.

Conditions

  • Cognition
  • Multiomics
  • Microbiome Analysis
  • Metabolome
  • Proteome
  • Metagenome
  • Probiotics Supplement
  • Gut-brain Axis
  • Pilot Study
  • Adult
  • Sleep

Interventions

DIETARY_SUPPLEMENT

Probiotic Supplementation (Lactobacillus plantarum)

This probiotic is a proprietary food-grade supplement that is not yet commercially available or CE-marked.

Sponsors & Collaborators

  • Healthspan Biotics

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-07-01
Completion
2027-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07457242 on ClinicalTrials.gov